Cryotherapy for Prostate Cancer: What We Know, What We Need to Know

Journal of Urology

Volumn 180, Issue 2, 2008, Pages 437-438

  Theodorescu, Dan ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADJUVANT THERAPY; BRACHYTHERAPY; CRYOTHERAPY; EDITORIAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE;

CLINICAL TRIALS AS TOPIC; CRYOTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PATIENT SELECTION; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 46449092674     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.05.081     Document Type: Editorial

References (5)

1. Akakura K., Suzuki H., Ichikawa T., Fujimoto H., Maeda O., and Usami M. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol 36 (2006) 789
2. Chin J.L., Ng C.K., Touma N.J., Pus N.J., Hardie R., and Abdelhady M. Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis 11 (2008) 40
3. Holmberg L., Bill-Axelson A., Helgesen F., Salo J.O., Folmerz P., and Haggman M. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347 (2002) 781
4. Nejat R.J., Rashid H.H., Bagiella E., Katz A.E., and Benson M.C. A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy. J Urol 164 (2000) 1891
5. Hoffman M.A., DeWolf W.C., and Morgentaler A. Is low serum free testosterone a marker for high grade prostate cancer?. J Urol 163 (2000) 824